Home
About Us
Pharmaceutical Industry
Research & Development
Regulatory Affairs
Quality Assurance
Quality Control
Production Department
Project Management
Environmental, Health & Safety (EHS)
Computer System Validation
Microbiology
Pharma SOPs
QA SOP’s
QC SOP’S
Microbiology SOP’s
Production SOP’s
General SOP’s
Clinical Research
Pharmacovigilance
Medical Coding
Courses
Videos
Job Notifications
Select Page
Blogs
Home
Blogs
Guideline on good pharmacovigilance practices (GVP): Module XVI Addendum II – Methods for evaluating effectiveness of risk minimisation measures
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP) Module XVI – Risk minimisation measures
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices: Module XV – Safety communication
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices: Module X – Additional monitoring
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP): Module IX – Signal management
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP): Module VIII Addendum I – Requirements and recommendations for the submission of information on non-interventional post-authorisation safety studies
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP) – Module VIII – Post-authorisation safety studies
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP): Module VII – Periodic safety update report
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP) – Module VI Addendum I – Duplicate management of suspected adverse reaction reports
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP) – Module VI – Collection, management and submission of reports of suspected adverse reactions to medicinal products
Dr. Yashashwini Reddy
June 25, 2025
No Comments
Pharmacovigilance
1
2
3
…
71
next »
Popular Categories
Clinical data Management
(4)
Clinical Research
(5)
Clinical SAS
(1)
Computer System Validation
(8)
Engineering Department
(7)
Environmental, Health & Safety (EHS)
(7)
General SOP’s
(1)
Medical Coding
(11)
Microbiology
(13)
Microbiology SOP’s
(3)
Pharmacovigilance
(28)
Pharma SOPs
(98)
Production Department
(210)
Production SOP’s
(6)
Project Management
(1)
QA SOP’s
(1)
QC SOP’S
(4)
Quality Assurance
(92)
Quality Control
(214)
Regulatory Affairs
(43)
Research & Development
(41)
Warehouse
(4)
Recent Post
Guideline on good pharmacovigilance practices (GVP): Module XVI Addendum II – Methods for evaluating effectiveness of risk minimisation measures
Guideline on good pharmacovigilance practices (GVP) Module XVI – Risk minimisation measures
Guideline on good pharmacovigilance practices: Module XV – Safety communication
Guideline on good pharmacovigilance practices: Module X – Additional monitoring
Guideline on good pharmacovigilance practices (GVP): Module IX – Signal management
Hello
Chat now via Whatsapp